stella
beta
Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer — Stella
Recruiting
Back to Triple Negative Breast Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Australia
Kinghorn Cancer Centre, Darlinghurst, New South Wales
View full record on ClinicalTrials.gov